How Much Did InStockRx Raise?
Funding & Key Investors

InStockRx has successfully secured a major strategic investment, marking a pivotal milestone in its growth trajectory within the pharmaceutical supply chain sector. The company has reached a significant milestone with a $5M valuation, bolstered by a $5M injection of capital. This latest financing round underscores the market's confidence in the platform's ability to address critical inefficiencies in medication procurement and inventory management for US-based pharmacies.

By facilitating a secure, compliant B2B marketplace, InStockRx is effectively positioning itself as a vital infrastructure layer for independent and chain pharmacies alike. The influx of capital will be instrumental in scaling operations and expanding the reach of its automated analytics suite, which is designed to mitigate the financial burden of deadstock and surplus inventory.

What is InStockRx?

InStockRx
SoftwareHealthcare SoftwareDrug Stores & Pharmacies

InStockRx operates as a specialized B2B marketplace tailored for the unique regulatory and operational requirements of the US pharmacy industry. The platform serves as a digital clearinghouse where licensed pharmacies can liquidate excess inventory and source essential medications, thereby optimizing cash flow and operational efficiency. By enabling the formation of trading partner groups, InStockRx fosters a collaborative ecosystem that enhances the liquidity of both brand and generic pharmaceuticals. The platform's core value proposition lies in its automated analytics engine, which provides actionable insights into stock levels and facilitates seamless medication transfers between participating locations. This model not only reduces waste but also ensures that pharmacies can maintain optimal stock levels without the overhead of traditional wholesale procurement cycles.

How much funding has InStockRx raised?

InStockRx has raised a total of $5M across 1 funding round:

2026

Series A

$5M

Series A (2026): $5M with participation from FCA Venture Partners and Techstars

Key Investors in InStockRx

FCA Venture Partners

A healthcare-focused investment firm with over 15 years of experience, specializing in backing companies that improve patient care, empower providers, and reduce systemic costs.

Techstars

A global investment firm and accelerator network that connects startups with capital, mentorship, and corporate partners to foster thriving entrepreneurial ecosystems.

What's next for InStockRx?

With this major enterprise-level funding, InStockRx is poised to accelerate its market penetration and enhance its technological infrastructure. The strategic roadmap likely includes the expansion of its automated analytics capabilities and the onboarding of a broader network of licensed pharmacy partners. As the company transitions from its initial scaling phase to a more mature market presence, the focus will shift toward deepening its integration with pharmacy management systems and refining its predictive algorithms for inventory demand. By leveraging the expertise of its venture partners, InStockRx is well-positioned to redefine the standards of pharmaceutical inventory management, ultimately driving greater cost-efficiency and operational resilience across the healthcare supply chain.

See full InStockRx company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

SoftwareStorage & System Management SoftwareSecurity Software
Content & Collaboration SoftwareSoftware
Content & Collaboration SoftwareSoftware
Engineering SoftwareSoftware

Frequently Asked Questions Regarding InStockRx Financial Insights

What are the most recent funding rounds that InStockRx has completed, and what were the funding rounds?
InStockRx has recently completed 1 funding rounds: Series A on Jun 30, 2026.
What is the total amount of funding InStockRx has raised to date?
InStockRx has raised a total of $5M in funding to date.
How many funding rounds has InStockRx completed?
InStockRx has completed 1 funding rounds.
How much funding did InStockRx raise in its most recent funding round?
InStockRx raised $5M in its most recent funding round.
Who are the lead investors in InStockRx's latest funding round?
The lead investor in InStockRx's latest funding round was FCA Venture Partners. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in InStockRx's history?
The largest funding round in InStockRx's history was $5M.
See more information about InStockRx